When patients leave the waiting room of their provider, their concerns can go with them. With the help of social media channels like Facebook and Twitter, those concerns can be addressed while information is shared in a new and effective manner.
Panelists Peter L. Salgo, MD; Phillip Barbour; Joshua D. Lee, MD, PhD; Jac A. Charlier, MPA; and Jonathan Grand highlight their final thoughts on the future of drug addiction and its treatment approaches.
The common multiple sclerosis treatment, according to a study out of Duke, may do very little for as many as half of people with the disease. In a mouse model of MS, they identified different disease pathways in those resistant to the treatment, raising questions about the heterogeneity of MS.